Occudo Quantitative Strategies’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-20,131
Closed -$279K – 1498
2022
Q3
$279K Buy
20,131
+6,841
+51% +$102K 0.02% 871
2022
Q2
$191K Sell
13,290
-822
-6% -$14.3K 0.02% 921
2022
Q1
$319K Sell
14,112
-51,279
-78% -$995K 0.03% 795
2021
Q4
$1.23M Buy
65,391
+49,069
+301% +$1.31M 0.11% 289
2021
Q3
$536K Buy
16,322
+10,789
+195% +$402K 0.06% 511
2021
Q2
$236K Buy
+5,533
New +$216K 0.04% 685
2021
Q1
– Sell
-4,986
Closed -$218K – 977
2020
Q4
$218K Buy
+4,986
New +$188K 0.07% 522

Other funds holding CSII

Occudo Quantitative Strategies's CSII Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2022, closing a stake of 20,131 shares — an estimated $279K sold.

Occudo Quantitative Strategies first reported a position in CSII in Q4 2020 and held it in 7 quarters. The position peaked at $1.23M in Q4 2021. 161 funds tracked by Wall St. Rank hold CSII as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Cardiovascular Systems, Inc. position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 20,131 Cardiovascular Systems, Inc. shares in Q4 2022, an estimated $279K.
  • Occudo Quantitative Strategies first reported a position in Cardiovascular Systems, Inc. in Q4 2020 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Cardiovascular Systems, Inc. position peaked at $1.23M in Q4 2021.
  • 161 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.